[1]
C. Serafinceanu, A. Crăciun, C. Dobjanschi, and V. Elian, “SGLT2 INHIBITORS – IS THE PARADIGM IN TYPE 2 DIABETES MELLITUS MANAGEMENT CHANGING ?”, RJDNMD, vol. 21, no. 4, pp. 261-265, Dec. 2014.